Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors

Abstract

This invention is directed to compound, which are PDE10A enzyme inhibitor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I. The present invention further provides a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention also provides a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.